Jury Still Out on CSL, page-27

@W534220

You must be a clairvoyant. Almost nobody thought CSL was a 'bargain' when it floated. The institutions avoided it like the plague. In fact the price fell a few weeks after listing to $2.25 (pre-split).

When CSL was a floated it was hopelessly inefficient government research and manufacturing facility where researchers had free reign. Financial discipline and a profit motive was non-existent. The only thing of any real value was the plasma fractionation plant.The only reason it became highly valuable company was the decision of Brian McNamee to change direction totally. That is the main why the price tanked when he was diagnosed with cancer.

Double digit growth doesn't continue forever. CSL is probably as big as it will ever get without a merger or takeover (very unlikely to be approved).